Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Avastin
Avastin
3 Big Biotech Stocks With Big-Time Catalysts
Motley Fool
Sun, 04/9/17 - 12:36 pm
Regeneron
Praluent
Amgen
biosimilars
Amjevita
Humira
ABP-215
Avastin
ABP-980
Herceptin
Celgene
ozanimod
The 19 Best-Selling Prescription Drugs of All-Time
Motley Fool
Mon, 03/13/17 - 11:29 am
Lipitor
Humira
Seretide
Remicade
Plavix
Enbrel
Rituxan
Herceptin
Avastin
Nexium
Zyprexa
The Demise of the BPCIA Patent Dance?
FDA Law Blog
Fri, 03/3/17 - 09:40 am
BPCIA
patents
Genentech
Amgen
Sandoz
Avastin
Amgen and the BPCIA Patent Dance – Redux
FDA Law Blog
Mon, 02/20/17 - 10:07 am
Amgen
patents
BPCIA
FDA
Sandoz
Neupogen
generics
Genentech
Avastin
Amgen, Allergan Seek EU OK for Avastin Biosimilar
Investopedia
Mon, 12/5/16 - 09:59 am
Amgen
Allergan
Avastin
biosimilars
Europe
ABP 215
non-squamous lung cancer
Amgen, Allergan step up to challenge Roche's Avastin with FDA biosim filing
Fierce Pharma
Wed, 11/16/16 - 09:57 am
Amgen
Allergan
Roche
Avastin
biosimilars
FDA
ABP 215
Roche adjusts Avastin franchise defense plans as PhII successor fails a key study
Endpoints
Fri, 10/21/16 - 10:01 am
Roche
Avastin
Vanucizumab
Roche rules out quality problems with Avastin in India
BioPharma Dive
Sat, 04/16/16 - 04:02 pm
Roche
Avastin
India
off-label
India reclears Roche's Avastin for off-label eye sales
Fierce Pharma Marketing
Mon, 03/14/16 - 05:53 pm
India
Roche
Avastin
off-label
Roche's pharma chief sees no 'short term' pricing pressure on its cancer blockbusters
Fierce Pharma
Mon, 02/1/16 - 01:49 pm
Roche
drug pricing
Rituxan
Avastin
Herceptin
Off-label use of Avastin in India hospitalizes 15, sales halted in two states
BioPharma Dive
Wed, 01/20/16 - 09:35 pm
Avastin
India
off-label
Roche
wet age-related macular degeneration
Biosimilars Are Coming After Big Pharma's Bottom Line
Fortune
Tue, 01/12/16 - 02:37 pm
Big Pharma
biosimilars
Roche
AbbVie
MabThera
Herceptin
Avastin
Humira
Janssen
Remicade
Roche CEO Slams `Stupid' U.K. Decision to Drop Some Cancer Drugs
Bloomberg
Tue, 09/8/15 - 08:22 am
Roche
Pharma CEOs
UK
cancer
Avastin
Severin Schwan
Eylea erodes Lucentis, Avastin market share
Medical Marketing and Media
Tue, 08/4/15 - 06:10 pm
Eylea
Lucentis
Avastin
Regeneron
Roche/Genentech
Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar
Fierce Pharma Marketing
Wed, 07/22/15 - 09:36 pm
biosimilars
AbbVie
Roche
Amgen
Rituxan
Herceptin
Avastin
Neupogen
Neulasta
Epogen
Humira
Perjeta
Gazyva
Did Novartis try to sabotage Avastin ophthalmic trials?
BioPharma Dive
Mon, 04/6/15 - 10:54 am
Novartis
Avastin
Roche
Lucentis
BMJ: Novartis tried to 'scupper' trials to protect Lucentis from cheap Avastin
Fierce Pharma
Thu, 04/2/15 - 11:52 am
Novartis
clinical trials
Roche
Avastin
Lucentis
Genentech denies knowledge of distribution-related problems
BioPharma Dive
Thu, 03/5/15 - 11:12 am
Genentech
distribution
Avastin
Herceptin
Rituxan
Genentech Distribution Shift for Cancer Meds Delays Patient Care: Survey
WSJ Pharmalot
Mon, 03/2/15 - 12:29 pm
Genentech
Avastin
Rituxan
Herceptin
distribution
UK doctors lobby for off-label Avastin use
Medical Marketing and Media
Tue, 02/24/15 - 06:59 pm
UK
Avastin
off-label
Lucentis
wet age-related macular degeneration
Roche
Novartis
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »